Welcome to LookChem.com Sign In|Join Free
  • or
1,2,5-Oxadiazole-3-carbonitrile,4-nitro-(9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

159014-14-9

Post Buying Request

159014-14-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

159014-14-9 Usage

Chemical structure

A nitro-substituted derivative of 1,2,5-oxadiazole-3-carbonitrile

Family

Oxadiazole family of compounds

Industry use

Commonly used in the pharmaceutical industry for the synthesis of various drugs and pharmaceutical products

Biological activities

Has shown potential biological activities

Pharmacological properties

Has shown potential pharmacological properties

Drug discovery and development

Valuable compound for drug discovery and development

Potential use

Studied for its potential use in the treatment of various diseases and medical conditions

Versatility

Versatile compound with potential applications in medicine and pharmaceuticals

Check Digit Verification of cas no

The CAS Registry Mumber 159014-14-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,0,1 and 4 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 159014-14:
(8*1)+(7*5)+(6*9)+(5*0)+(4*1)+(3*4)+(2*1)+(1*4)=119
119 % 10 = 9
So 159014-14-9 is a valid CAS Registry Number.

159014-14-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-4-cyanofurazan

1.2 Other means of identification

Product number -
Other names 3-cyano-4-nitrofurazan

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:159014-14-9 SDS

159014-14-9Downstream Products

159014-14-9Relevant academic research and scientific papers

Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for Glucuronidation

Anderhub, Simon,Braun, Floriane,Hoffmann, Thomas,Hornberger, Martin,Kinzel, Olaf,Kleymann, Gerald,Morschhaeuser, Barbara,Pinto, Sheena,Steeneck, Christoph

, (2020)

Following the impressive success of checkpoint inhibitors in the treatment of cancer, combinations of IDO1 inhibitors with PD-1/PD-L1 antibodies are in clinical development aiming to increase response rates. Using the hydroxyamidine pharmacophore of the IDO1 inhibitor INCB14943 as a starting point for the design of new inhibitors, the potential shortcomings of extensive hydroxyamidine glucuronidation in humans was addressed. Compounds were optimized using a stability assay with recombinant UGT1A9 enzyme together with the measurement of glucuronide formation in human hepatocytes. Optimized analog 24 showed cellular and biochemical IDO1 IC50 values in the low nanomolar range, a suitable in vitro ADME/PK profile, and efficacy in an animal model of cancer. In a humanized liver mouse model the lead compound exhibited significantly reduced glucuronidation compared to epacadostat (2).

NOVEL SUBSTITUTED N'-HYDROXYCARBAMIMIDOYL-1,2,5-OXADIAZOLE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS

-

Page/Page column 31, (2018/03/25)

Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Formula (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

SUBSTITUTED N-HYDROXYAMIDINOHETEROCYCLES AS MODULATORS OF INDOLEAMINE 2,3- DIOXYGENASE

-

Page/Page column 54, (2018/05/24)

The invention provides modulators of indoleamine 2,3-dioxygenase (IDO1) and their use in the prophylaxis and/or treatment of IDO1-mediated diseases. Specifically, the present invention provides compounds according to Formula (I) an enantiomer, diastereomer, tautomer or pharmaceutically acceptable salt thereof.

An Ag(i) energetic metal-organic framework assembled with the energetic combination of furazan and tetrazole: Synthesis, structure and energetic performance

Qu, Xiao-Ni,Zhang, Sheng,Wang, Bo-Zhou,Yang, Qi,Han, Jing,Wei, Qing,Xie, Gang,Chen, San-Ping

supporting information, p. 6968 - 6973 (2016/05/19)

A novel Ag(i) energetic MOF [Ag16(BTFOF)9]n·[2(NH4)]n (1) assembled with Ag(i) ions and a furazan derivative, 4,4′-oxybis[3,3′-(1H-5-tetrazol)]furazan (H2BTFOF) was successfully synthesized and structurally characterized, featuring a three-dimensional porous structure incorporating ammonium cations. The thermal stability and energetic properties were determined, revealing that the 3D energetic MOF had an outstanding insensitivity (IS > 40 J), an ultrahigh detonation pressure (P) of 65.29 GPa and a detonation velocity (D) of 11.81 km cm-3. In addition, the self-accelerating decomposition temperature (TSADT) and the critical temperature of thermal explosion (Tb) are also discussed in detail. The finding exemplifies that the assembly strategy plays a decisive role in the density and energetic properties of MOF-based energetic materials.

A new family of energetic salts based on oxy-bridged bis(dinitromethyl)furazan: Syntheses, characterization and properties

Li, Hui,Zhao, Feng-Qi,Wang, Bo-Zhou,Zhai, Lian-Jie,Lai, Wei-Peng,Liu, Ning

, p. 21422 - 21429 (2015/03/30)

Energetic salts based on oxy-bridged bis(dinitromethyl)furazan (2) were synthesized and fully characterized by NMR (1H and 13C), IR spectroscopy, elemental analysis as well as differential scanning calorimetry (DSC). The crystal structures of neutral 2, its ammonium salt (4), guanidinium salt (7) and guanidylguanidinium salt (9) were also determined by single-crystal X-ray diffraction. Except for hydroxylammonium salt (5), all the remaining salts exhibit good thermal stabilities with decomposition temperature above 180 °C. Furthermore, the densities of salts ranged from 1.65 g cm-3 to 1.88 g cm-3. Theoretical calculations provided detonation pressures and velocities for the energetic salts within the range of 24.9-38.0 GPa and 7582.2-9072.7 m s-1, respectively.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 159014-14-9